or Try an Advanced Search...

    Recent News for XNCR - Xencor, Inc.

    Date Title
    Aug 5 Xencor Reports Second Quarter 2024 Financial Results
    Jun 22 Xencor (NASDAQ:XNCR) shareholders have endured a 52% loss from investing in the stock five years ago
    Jun 13 Xencor to regain rights from J&J for plamotamab
    Jun 13 Xencor Regains CD20 x CD3 Bispecific T-Cell Engager
    Back to the Main XNCR Page...